Moderna

Forecast & Rating23 analysts currently cover Moderna, with about 17.4% giving a positive rating — meaning they expect the stock to rise. The average price target is $138.37, about 37.6% downside from the current price of $221.72. Price targets range from $45.00 to $251.00 — a wide spread, showing clear disagreement over just how much Moderna can rise. Historically, about 55.8% of past price targets were eventually met, which adds credibility. For you, this means most institutions are cautious on Moderna's outlook. Data as of Oct 30, 2026; for reference only and not investment advice.